Hepatitis C Is Rapidly Spreading—And Baby Boomers Are Most At-Risk
June 14, 2017
Wisconsin prisons spend $10M treating hepatitis C
June 15, 2017
Show all

MS Injection-tracking Products from Bayer Receive FDA Approval

A product related to multiple sclerosis treatment earns FDA approval.

The U.S. Food and Drug Administration has approved a supplemental biologics license application for two Bayer products that help multiple sclerosis patients keep track of their injections of Betaseron (interferon beta-1b).

The products are the myBETAapp and the Betaconnect Navigator software. A biologics license application is a request for permission to market a biologic product.

Patients with relapsing-remitting MS (RRMS) can use the electronic Betaconnect auto-injector to administer Betaseron, a prescription medicine that reduces MS relapses.

Read full article: MS Injection-tracking Products from Bayer Receive FDA Approval

Read Full Article: MS Injection-tracking Products from Bayer Receive FDA Approval

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.